Dear Reader,
Welcome to the final issue of Drug Safety for 2021.
I wish to reflect on this year’s achievements, and to thank all those who have contributed their time and effort to guarantee the quality of the content published in the journal.
I would like to start by thanking the authors of the articles published in Drug Safety over the course of 2021. In 2021, over 115 articles have been published. The enthusiasm of all authors for their chosen fields and their willingness to contribute content to the journal are crucial for its continued
The high quality of content published in Drug Safety has been reflected in the most recent Journal Impact Factor of 5.606 (placing the journal in the first quartile of the Pharmacology & Pharmacy, Public, Environmental & Occupational Health, and Toxicology categories) and CiteScore™ of 6.7 (placing the journal in the first quartile of the Pharmacology and Toxicology category). Further, Drug Safety has published content in a timely manner, with an average time from submission to first decision of 19 days.
The COVID-19 pandemic has continued to present many challenges and I would like to thank all who have contributed to ensuring the journal has thrived despite the ongoing issues.
The quality of published articles is also testament to the diligence of the peer reviewers. I would like to acknowledge the following individuals who acted as reviewers for Drug Safety in the last 12 months:
Adeleke Adewumi, Australia
Iris Ahronowitz, USA
Joachim Alexandre, France
Mohammed A. Al-Garadi, USA
Thamir M. Alshammari, Saudi Arabia
Susan E. Andrade, USA
Hugo Arlegui, France
Barbara Arone, USA
Mark Avigan, USA
Phil Ayers, USA
Priya Bahri, UK
Marian K. Bakker, The Netherlands
Robert Ball, USA
Juan M. Banda, USA
Ullas Batra, India
Subhrojyoti Bhowmick, India
Steven T. Bird, USA
Pierre-Olivier Blotière, France
Udo Bonnet, Germany
Taxiarchis Botsis, USA
Ian W. Boyd, Australia
Martin J. Brodie, UK
Cheryl Broussard, USA
Gianmario Candore, UK
Bruce C. Carleton, Canada
Wendy C. Castillo, USA
Chinmay Chakraborty, India
Cindy H. Chau, USA
Laurent Chouchana, France
Wen-Hung Chung, Taiwan, Republic of China
Ethel L. Ciampi, Chile
Sarah Clark, USA
Stanley B. Cohen, USA
Trevor Cohen, USA
Jennifer Corny, France
Anthony R. Cox, UK
Paola M. Cutroneo, Italy
Hong-Jie Dai, Taiwan, Republic of China
Gerald J. Dal Pan, USA
Gaby Danan, France
Francisco J. de Abajo, Spain
Sieta T. de Vries, The Netherlands
Simone de Vries Lentsch, The Netherlands
Jean-Christophe Delumeau, Singapore
Michael Doerks, Germany
Antonios Douros, Canada
Brian D. Edwards, UK
Angelique Egberts, The Netherlands
Efe Eworuke, USA
Michelle A. Farrar, Australia
Manuela Farris, Italy
Steven R. Feldman, USA
Carmen Ferrajolo, Italy
James Fingleton, New Zealand
Robert Fleischmann, Germany
Yara D. Fragoso, Brazil
Bryony D. Franklin, UK
Christian Funck-Brentano, France
Chiara Gastaldon, Italy
Lucie M. Gattepaille, Sweden
David Gerrett, UK
Thijs J. Giezen, The Netherlands
Rajdeep Gill, USA
Alicia Gilsenan, USA
Joanna Girling, UK
Thomas Goedecke, The Netherlands
Sinem E. Gulmez, Turkey
Abenah Harding, USA
Gil Hardy, New Zealand
Rafael Harpaz, USA
Alys Havard, Australia
Gary Haynes, USA
Ioline D. Henter, USA
Thomas Herdegen, Germany
Andrew Hill, UK
Keith B. Hoffman, USA
Bruce P.J. Hugman, UK
Krista F. Huybrechts, USA
Mihael C. Ichim, Romania
Pedro Inacio, Finland
Ambrose O. Isah, Nigeria
Deanna Jannat-Khah, USA
Lauren L. Jantzie, USA
Maria Jędrzejowska, Poland
G. Morgan Jones, USA
Hendree Jones, USA
Mark Jones, Australia
Kevin Klein, The Netherlands
Peter Knapp, UK
Kaoru Koyama, Japan
Kristian Kragholm, Denmark
Jayashri Kulkarni, Australia
Samantha Lane, UK
Dominique Larrey, France
Simona Lattanzi, Italy
Anne Leuppi-Taegtmeyer, Switzerland
Amalia Levy, Israel
Kathy Li, Canada
Sophie Liabeuf, France
Wen-Yang Lin, Taiwan, Republic of China
Feifan Liu, USA
Zhichao Liu, USA
Angela Lupattelli, Norway
Andrea D. Maderal, USA
Isabel Mafra, Portugal
Arjun Magge, USA
Simran D.S. Maggo, New Zealand
Ian D. Maidment, UK
Michael Makris, UK
Alexandre E. Malek, USA
Alice Mann, Canada
Miriam Manosa, Spain
Judith C. Maro, USA
Géric Maura, France
Mark J. McKeage, New Zealand
Úna McMenamin, UK
Timothe Menard, Switzerland
Jae Sun Min, USA
Takuo Mizukami, Japan
Thomas J. Moore, USA
Takeshi Morimoto, Japan
Aldo Morrone, Italy
Marco Mula, UK
Judy Mullan, Australia
Monica A. Munoz, USA
Lisa Mustachio, USA
Mamoru Narukawa, Japan
Pantelis Natsiavas, Greece
Andrea Negro, Italy
Victoria Newbould, UK
Phung Anh Nguyen, Taiwan, Republic of China
Arjen F. Nikkels, Belgium
Hedvig Nordeng, Norway
Roberta Noseda, Switzerland
Hiroyuki Ohbe, Japan
Yusuke Okuma, Japan
Sten Olsson, Sweden
Ambrogio Orlando, Italy
Alexandra C. Pacurariu, UK
Dimitris Papanikolaou, USA
Lianne Parkin, New Zealand
Laura Pazzagli, Sweden
Robert W. Platt, Canada
Elisabetta Poluzzi, Italy
Gregory Powell, USA
Jingjing Qian, USA
Susana Quijano-Roy, France
Suraj Rajasimhan, USA
Laura B. Ramsey, USA
Emanuel Raschi, Italy
Raj Ratwani, USA
Annette Regan, USA
Kristian Reich, Germany
Melissa Reyes, USA
Javier Rojo, USA
Victoria Rollason, Switzerland
Debabrata Roy, UK
Gualberto Ruaño, USA
Martin Salzmann, Germany
Abhishek Sathe, USA
Tania Schink, Germany
Georgios Schoretsanitis, USA
Martijn J. Schuemie, USA
David L. Scott, UK
Marcial Sebode, Germany
Joshua M. Sharfstein, USA
Lee S. Simon, USA
Susan M. Sinclair, USA
Alok Singh, India
Jim Slattery, UK
Samantha Smalley, USA
Meredith Y. Smith, USA
D. Max Smith, USA
Rachel E. Sobel, USA
Lucía Cea Soriano, Spain
James D. Stamey, USA
Holger Storf, Germany
Valerie Strassmann, The Netherlands
Loreen Straub, USA
Samuel Suen, USA
Øyvind S. Svendsen, Norway
Reo Tanoshima, Japan
Michael V. Tatley, New Zealand
Fernanda Tavares-Da-Silva, Belgium
Gisela Terwindt, The Netherlands
Rolf Teschke, Germany
Gita Thanarajasingam, USA
Lina Titievsky, USA
Antonella Tosti, USA
Shinya Tsuzuki, Japan
Heleen van der Sijs, The Netherlands
Sander van Doorn, The Netherlands
Marleen van Gelder, The Netherlands
Florence van Hunsel, The Netherlands
Mauro Venegoni, Italy
Katia Verhamme, The Netherlands
Gianluca Voglino, Italy
Kaicheng Wang, USA
Michelle Wang, USA
Sabine Weber, Germany
Wendy J. Weber, USA
Rene Westhovens, Belgium
Cameron Wright, Australia
Richard D. Wyss, USA
Satoshi Yokoyama, Japan
Seng Chan You, Republic of Korea
Manal M. Younus, Iraq
Siyan Zhan, China
I am also very grateful to all members of the journal’s Honorary Editorial Board (listed below), who have acted as peer reviewers and authors, and have provided guidance on journal content, policy and processes.
G. Caleb Alexander, USA
Giuseppe Andò, Italy
Laurent Azoulay, Canada
Joanne Barnes, New Zealand
David W. Bates, USA
Frank M.C. Besag, UK
Einar S. Björnsson, Iceland
Benjamin D. Bray, UK
Nicholas Buckley, Australia
Nabarun Dasgupta, USA
Ric O. Day, Australia
Fabrizio De Ponti, Italy
Alexander N.O. Dodoo, Ghana
I. Ralph Edwards, Sweden
Antonie C.G. Egberts, The Netherlands
Adolfo Figueiras, Spain
Joshua Gagne, USA
Stephen A. Goldman, USA
Staffan Hägg, Sweden
Kenneth Y. Hartigan-Go, Philippines
Laurence Howes, Australia
David Hunt, UK
Susan Jick, USA
Stephan Krähenbühl, Switzerland
Kiyoshi Kubota, Japan
Joan-Ramon Laporte, Spain
Deborah Layton, UK
Hervé Le Louet, Sweden
James H. Lewis, USA
David F.L. Liew, Australia
Marie Lindquist, Sweden
Yoon K. Loke, UK
Christopher R. Meier, Switzerland
Ronald Meijboom, The Netherlands
Peter G.M. Mol, The Netherlands
Jean-Louis Montastruc, France
Nichoals Moore, France
G. Niklas Norén, Sweden
Munir Pirmohamed, UK
Ruth L. Savage, New Zealand
Nigam Shah, USA
Rashmini R. Shah, UK
Saad Shakir, UK
Neil Shear, Canada
Olav Spigset, Norway
Janet Sultana, Malta
Nicholas P. Tatonetti, USA
Gianluca Trifirò, Italy
Marco Tuccori, Italy
Eugene P. van Puijenbroek, The Netherlands
Ian C.K. Wong, UK
Li Zhang, China
Springer Nature has continued to support the global response to COVID-19 by making all relevant content immediately and freely available. Indeed, Drug Safety has published a number of papers relevant to the COVID-19 pandemic that are free to access.
In terms of other important company initiatives, the Springer Nature ‘Sustainable Development Goals (SDG) Programme’ is aiming to connect researchers who are tackling the world’s toughest challenges with practitioners in policy and business, while the ‘Women in Science’ initiative aims to help empower more women scientists to achieve scientific excellence. Finally, I am delighted to inform you that Springer Nature is now carbon neutral for its direct operations (offices, fleet and flights) and earlier this year signed The Climate Pledge, making a commitment to be Net Zero carbon by 2040.
Returning to Drug Safety, the editorial program for 2022 is well under way, and I am looking forward to bringing you many high-quality and authoritative articles over the coming year.
I thank you for your continued support.
With best wishes,
Nitin Joshi
Editor-in-Chief, Drug Safety